Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma total assets
Total assets on the balance sheet at the end of each period.
Benitec Biopharma's total assets was $182.62M at Jun 30, 2026. For fiscal 2026 it was $182.62M, up 83.4% from the year before. The highest annual figure on record is $182.62M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $182.62M | +83.4% |
| FY2025 | Jun 30, 2025 | $99.59M | +90.8% |
| FY2024 | Jun 30, 2024 | $52.21M | +1069.6% |
| FY2023 | Jun 30, 2023 | $4.46M | -25.3% |
| FY2022 | Jun 30, 2022 | $5.97M | -72.1% |
| FY2021 | Jun 30, 2021 | $21.38M | +84.5% |
| FY2020 | Jun 30, 2020 | $11.59M | -39.8% |
| FY2019 | Jun 30, 2019 | $19.24M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $182.62M | +83.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $187.00M | +77.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $190.68M | +141.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $96.03M | +39.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $99.59M | +90.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $105.21M | +601.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $79.07M | +270.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $68.77M | +154.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $52.21M | +1069.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $15.00M | +82.5% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $21.35M | +79.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $27.05M | +49.3% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $4.46M | -25.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $8.22M | -18.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $11.91M | -15.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $18.12M | +1.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $5.97M | -72.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $10.06M | -25.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $14.01M | -9.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $17.84M | +100.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $21.38M | +84.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $13.43M | -30.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $15.51M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $8.92M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $11.59M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $19.24M | – |
See a number that looks wrong?